Patent · US Active

Lipid formulated dsRNA targeting the PCSK9 gene

US8598139B2 · kind B2 · utility

12Cited by
4References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 7, 2012
Grant dateDec 3, 2013
Priority date—
Expiry dateAug 7, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/3515
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to composition and methods using lipid formulated siRNA targeted to a PCSK9 gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.